Preventice Technologies (now Boston Scientific Cardiac Diagnostics)
About Preventice Technologies (now Boston Scientific Cardiac Diagnostics)
Preventice Technologies, now operating as Boston Scientific Cardiac Diagnostics, was a pioneering healthcare AI company specializing in mobile health solutions and remote patient monitoring services. Prior to its acquisition, the company developed and offered a comprehensive portfolio of wearable cardiac monitors, notably the BodyGuardian™ family of devices. These small, non-invasive monitors were designed to continuously track and collect physiological data, including electrocardiograms (ECG), heart rate, respiration rate, and activity levels, for the diagnosis and management of cardiac arrhythmias such as atrial fibrillation, tachycardia, and bradycardia in ambulatory patients.
The core of Preventice’s offering was its fully-integrated, cloud-based PatientCare™ platform, which leveraged data analytics and advanced algorithms, including deep learning networks and artificial intelligence (AI), to provide near real-time insights into a patient’s heart condition. This technology aimed to enhance physician efficiency, improve diagnostic accuracy, and enable personalized treatment plans by delivering clinically significant data without interrupting patients’ daily lives. The integration of AI and human expertise was a key differentiator, supporting clinicians in making informed decisions and ultimately reducing care costs and improving health outcomes.
Boston Scientific acquired Preventice Solutions in March 2021, integrating its technologies into Boston Scientific Cardiac Diagnostics. This acquisition significantly expanded Boston Scientific’s rhythm management portfolio and established a stronger foothold in the high-growth ambulatory electrocardiography market. The combined entity continues to focus on providing comprehensive cardiac diagnostic solutions, from wearable monitors to advanced cardiac imaging, with an emphasis on early detection, continuous monitoring, and personalized patient care.
Focus Areas
Business Intelligence
| Key Investors | Boston Scientific Ventures, Vivo Capital, Merck Global Health Innovation Fund, Samsung Catalyst Fund, Novo Holdings, Mayo Clinic Ventures, CRG |
| Partnerships | Mayo Clinic, Samsung |
| Acquisitions | eCardio Diagnostics (2014); Acquired by Boston Scientific (2021) |
| Technology | Cloud-based platform, wearable cardiac monitors (BodyGuardian® family), mobile applications, BeatLogic® deep learning algorithms (AI operating system for ECG analysis) |
| FDA Clearances | Multiple (including 510(k) clearances for BodyGuardian Remote Monitoring System in 2012 and 2020) cleared products (estimated) |
What Physicians Need to Know
For physicians, Preventice Technologies (now Boston Scientific Cardiac Diagnostics) stands out by offering a powerful combination of accurate, AI-driven cardiac diagnostics and patient-friendly remote monitoring. The BeatLogicu2122 deep learning platform significantly reduces the burden of reviewing vast amounts of ECG data, providing precise detection and classification of arrhythmias, which can lead to more timely and informed treatment decisions. The BodyGuardianu00ae family of monitors, with its multi-modal capabilities (Holter, event, MCT in one device) and comfortable, waterproof design, enhances patient adherence and provides comprehensive data outside the clinical setting. This continuous connection and actionable data, integrated into a cloud-based platform, empower physicians to efficiently diagnose and manage cardiac patients, ultimately improving clinical outcomes and patient care pathways. The ability to receive data-rich reports and integrate them into EHRs streamlines workflow and allows for a focus on patient-specific treatment plans.
The cloud-based PatientCare Platform is designed for high compatibility with digital health platforms, offering opportunities to integrate with existing hospital information systems and telehealth solutions, including electronic health records (EHRs).
What the Web Says
Preventice Technologies, now Boston Scientific Cardiac Diagnostics, offers remote cardiac monitoring solutions, including the BodyGuardian family of wearable monitors. These devices are designed to detect and monitor cardiac arrhythmias, providing physicians with data for diagnosis and treatment. The company emphasizes patient comfort, data accuracy through AI and technician review, and seamless integration with healthcare systems. However, some users have reported issues with skin irritation from adhesives and discrepancies in symptom logging.
Overall: MixedStrengths
- Small, lightweight, and waterproof wearable monitors (BodyGuardian MINI/MINI PLUS).
- High diagnostic accuracy with AI-driven algorithms (BeatLogicu2122) and technician review.
- Fast report turnaround for timely diagnoses (24-48 hours average).
- Multiple business models and flexible solutions for physician practices.
- Integration with Electronic Medical Records (EMR) like Epic Aura for simplified workflows.
- Good work-life balance and benefits reported by some employees at Boston Scientific.
Limitations
- Skin irritation and allergic reactions to adhesive pads reported by some patients.
- Discrepancies in recorded patient-logged symptoms versus actual button presses.
- Issues with monitor functionality and connectivity.
- Poor customer service and communication regarding monitor issues and supplies.
- Some employees at Preventice Solutions reported toxic management, being underpaid, and lack of raises.
- Daily self-checks on some Boston Scientific devices can be noticeable and disliked by patients.
Based on reviews from: Samsung Business Insights, For Patients (Boston Scientific Cardiac Diagnostics), Trustpilot (Boston Scientific Reviews), Better Business Bureau (Boston Scientific Corporation), accessdata.fda.gov (MAUDE Adverse Event Report), Frost & Sullivan, Biobank News, Epic Showroom, Medical Technology Enterprise Consortium (MTEC), Boston Scientific Cardiac Diagnostics, PR Newswire, Reddit (r/Cardiology), Reddit (r/PVCs), Respiratory Care, Indeed.com (Preventice Solutions), Boston Scientific, Indeed.com (Boston Scientific), Bureau of Labor Statistics, G2
Last updated: 2026-07-18
Videos
News, demos, and interviews about Preventice Technologies (now Boston Scientific Cardiac Diagnostics).
Videos load interactively. If none appear, search YouTube for Preventice Technologies (now Boston Scientific Cardiac Diagnostics) →
Press & Coverage
Frequently Asked Questions
Comparisons
For a physician evaluating remote cardiac monitoring solutions, BodyGuardian Remote Monitoring System and Cardiomo both offer AI-powered wearable technology, but cater to slightly different needs. BodyGuardian, from Boston Scientific Cardiac Diagnostics, excels in comprehensive, multi-modal cardiac rhythm analysis for non-lethal arrhythmias. It integrates mobile cardiac telemetry, event monitoring, and Holter monitoring capabilities into a single […]
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]